Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Triple Negative Breast Neoplasms
×
capivasertib
×
Clear all
Filters
3
NCT03997123
2025-12-22
CAPItello-290
AstraZeneca
Phase 3
Active not recruiting
923 enrolled